In the current study, we observed that acute sorafenib incubation significantly inhibits the expression of GCN5L1 in HCC cells, however, sorafenib resistance is associated with increased GCN5L1 expression. The gene discussed is BLOC1S1; the disease is hepatocellular carcinoma.